Decitabine Intravenous and Insulin Glargine (U-300) Pens
Determining the interaction of Decitabine Intravenous and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: decitabine
Brand name: Dacogen
Synonyms: Decitabine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Decitabine Intravenous-Insulin glargine and lixisenatide
- Decitabine Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Decitabine Intravenous-Insulin glargine, recombinant Subcutaneous
- Decitabine Intravenous-Insulin glulisine
- Decitabine Intravenous-Insulin Glulisine (Cartridges and Pens)
- Decitabine Intravenous-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Declomycin
- Insulin Glargine (U-300) Pens-Decon-A
- Insulin Glargine (U-300) Pens-Deconamine (Chlorpheniramine and Pseudoephedrine Liquid)
- Insulin Glargine (U-300) Pens-Deconamine (Chlorpheniramine and Pseudoephedrine Tablets)
- Insulin Glargine (U-300) Pens-Deconex
- Insulin Glargine (U-300) Pens-Deconex DMX